Reivindicaciones
1. Antibiotic-containing bioceramic material with controlled-release of bioactive agents,characterized in that it comprises an ordered mesoporous silica material, one or several antibiotics suitable for the treatment of osteomyelitis and, optionally, a bacterial quorum sensing inhibiting peptide. 2. Antibiotic-containing bioceramic material with controlled-release of bioactive agents according to claim 1, where the ordered silica material is SBA-15. 3. Antibiotic-containing bioceramic material with controlled-release of bioactive agents according to the preceding claims, where the antibiotic is rifampicin, vancomycin, linezolid or a combination thereof. 4. Antibiotic-containing bioceramic material with controlled-release of bioactive agents, where the inhibiting peptide is RIP (RNA Inhibiting Peptide). 5. Use of the bioceramic material defined in claims 1-4 in the elaboration of a bone implant for the treatment of osteomyelitis.